Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise (EXETOR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Hospital Universitari de Bellvitge.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Josep M Cruzado, Hospital Universitari de Bellvitge
ClinicalTrials.gov Identifier:
NCT01561404
First received: March 20, 2012
Last updated: March 21, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)